Skip to content
- Genetic variants in African-American and Hispanic patients with breast cancer.
- Dutta P, Keung MY, Wu Y, Vadgama JV.
- Oncol Lett. 2022 Dec 16 [eCollection 2023 Feb];25(2):51. doi: 10.3892/ol.2022.13637.
- Estimating copy number to determine BRCA2 deletion status and to expect prognosis in localized prostate cancer.
- Nukaya T, Sumitomo M, Sugihara E, Takeda M, Nohara S, Tanishima S, Takenaka M, Zennami K, Takahara K, Shiroki R, Saya H.
- Cancer Med. 2023 Jan 16. doi: 10.1002/cam4.5617. Epub ahead of print.
- Shallow Whole-Genome Sequencing of Cell-Free DNA (cfDNA) Detects Epithelial Ovarian Cancer and Predicts Patient Prognosis.
- Bak SE, Kim H, Ho JY, Cho EH, Lee J, Youn SM, Park SW, Han MR, Hur SY, Lee SJ, Choi YJ.
- Cancers (Basel). 2023 Jan 15;15(2):530. doi: 10.3390/cancers15020530.
- A case report of biallelic CHEK2 heterozygous variant presenting with breast cancer.
- Soleimani T, Bourdon C, Davis J, Fortes T.
- Clin Case Rep. 2023 Jan 11 [eCollection 2023 Jan];11(1):e6820. doi: 10.1002/ccr3.6820.
- First-line Rucaparib Plus Bevacizumab Maintenance Completed One-Year in Germline BRCA1-Mutated Advanced Ovarian Cancer.
- Roy S, Ghosh J, Ganguly S, Biswas B, Bhaumik J.
- Cureus. 2022 Dec 13;14(12):e32493. doi: 10.7759/cureus.32493.